A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...
Disruptions in LDLR function or apoB100 mutations, as seen in FH, lead to low-density lipoprotein cholesterol (LDL-C) accumulation, triggering atherosclerosis. 3-hydroxy-3-methylglutaryl-coenzyme ...